Stock 0QAH MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Merck & Co., Inc. London S.E.

Equities

0QAH

US58933Y1055

Pharmaceuticals

Real-time Estimate Tradegate
Other stock markets
 09:15:22 17/06/2024 pm IST 		5-day change 1st Jan Change
119.3 EUR 0.00% Intraday chart for Merck & Co., Inc. +2.60% 0.00%
13/06 High-risk health workers can get routine Ebola vaccine, Gavi says RE
13/06 AbbVie inks immune disorder drug licensing deal with China's FutureGen RE

Business Summary

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (18%);

- sale of animal health products (9.4%);

- other (2.9%).

Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical
89.1 %
52,005 87.7 % 53,583 89.1 % +3.03%
Animal Health
9.4 %
5,550 9.4 % 5,625 9.4 % +1.35%
Other
1.5 %
1,728 2.9 % 907 1.5 % -47.51%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
47.4 %
27,206 45.9 % 28,480 47.4 % +4.68%
Europe, Middle East and Africa
22.0 %
14,493 24.4 % 13,254 22.0 % -8.55%
China
11.3 %
5,191 8.8 % 6,802 11.3 % +31.03%
Asia Pacific
5.4 %
3,614 6.1 % 3,225 5.4 % -10.76%
Japan
5.3 %
3,629 6.1 % 3,164 5.3 % -12.81%
Latin America
5.1 %
2,582 4.4 % 3,086 5.1 % +19.52%
Other
3.5 %
2,568 4.3 % 2,104 3.5 % -18.07%

Managers

Managers TitleAgeSince
Robert Davis CEO
 Chief Executive Officer 57 01/14/01
Caroline Litchfield DFI
 Director of Finance/CFO 55 01/90/01
Dave Williams CTO
 Chief Tech/Sci/R&D Officer 55 01/20/01
Joseph Romanelli IRC
 Investor Relations Contact 50 01/96/01
Peter Dannenbaum IRC
 Investor Relations Contact - 01/17/01
Andre Musto PRN
 Corporate Officer/Principal - 01/14/01
Brooke Hinkson PRN
 Corporate Officer/Principal - 01/15/01
Carol Bowden PRN
 Corporate Officer/Principal - 01/14/01
Dalton Smart AUD
 Comptroller/Controller/Auditor 58 01/09/01
James Matteucci PRN
 Corporate Officer/Principal - 01/03/01

Members of the board

Members of the board TitleAgeSince
Tom Glocer BRD
 Director/Board Member 63 27/07/27
Pamela Craig BRD
 Director/Board Member 67 01/15/01
Inge Thulin BRD
 Director/Board Member 69 01/18/01
Patricia Russo BRD
 Director/Board Member 71 01/95/01
Risa Lavizzo-Mourey BRD
 Director/Board Member 69 26/20/26
Robert Davis CEO
 Chief Executive Officer 57 01/14/01
Douglas Baker BRD
 Director/Board Member 65 24/22/24
Stephen Mayo BRD
 Director/Board Member 62 15/21/15
Kathy Warden BRD
 Director/Board Member 52 16/20/16
Christine Seidman BRD
 Director/Board Member 71 16/20/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,208,962 2,531,418,332 ( 70.77 %) 1,044,402,655 ( 29.20 %) 70.77 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.605 %
243,269,899 9.605 % 30 540 M €
BlackRock Advisors LLC
6.177 %
156,460,386 6.177 % 19 642 M €
STATE STREET CORPORATION
4.636 %
117,425,530 4.636 % 14 742 M €
Wellington Management Co. LLP
3.409 %
86,348,259 3.409 % 10 840 M €
Geode Capital Management LLC
2.227 %
56,411,229 2.227 % 7 082 M €
Fidelity Management & Research Co. LLC
2.058 %
52,116,893 2.058 % 6 543 M €
BlackRock Life Ltd.
1.703 %
43,121,867 1.703 % 5 414 M €
Eaton Vance Management
1.639 %
41,505,855 1.639 % 5 211 M €
Merrill Lynch International
1.484 %
37,576,885 1.484 % 4 717 M €
T. Rowe Price International Ltd.
1.170 %
29,639,517 1.170 % 3 721 M €
NameEquities%Valuation
Caixa DTVM SA
0.001503 %
304,520 0.001503 % 5 M €
BB Gestão de Recursos DTVM SA
0.000900 %
182,400 0.000900 % 3 M €
Safra Asset Management Ltda.
0.000318 %
64,500 0.000318 % 1 M €
Bram Bradesco Asset Management S/A DTVM
0.000205 %
41,594 0.000205 % 651 626 €
XP Allocation Asset Management Ltda.
0.000093 %
18,763 0.000093 % 293 948 €

Holdings

NameEquities%Valuation
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
10.32%
 13,443,693 10.32% 295,909,530 $
ENTRADA THERAPEUTICS, INC.
5.15%
 1,739,768 5.15% 26,914,211 $
XILIO THERAPEUTICS, INC.
4.02%
 1,483,414 4.02% 1,602,087 $
EVAXION BIOTECH A/S
12.13%
 2,297,884 12.13% 843,323 $

Company contact information

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com
address Merck & Co., Inc.(0QAH)

Group companies

NameCategory and Sector
MSD Regional Business Support Center GmbH
Logo MSD Regional Business Support Center GmbH

MSD Regional Business Support Center GmbH

Miscellaneous Commercial ServicesCommercial Services

Part of Merck & Co., Inc., MSD Regional Business Support Center GmbH is a German company that provides management consulting services. The company is based in Munich, Germany. Jutta König has been the CEO of the company since 2021.

Miscellaneous Commercial Services
Merck Holdings, Inc.
MSD International GmbH (Switzerland)
Logo MSD International GmbH (Switzerland)

MSD International GmbH (Switzerland)

Pharmaceuticals: MajorHealth Technology

Part of Merck & Co., Inc., MSD International GmbH (Switzerland) is a Swiss company that discovers, develops and markets human and animal health products. The company is located in Switzerland.

Pharmaceuticals: Major
Schering Plough International Finance Co. BV
MSD Human Health Holding BV
Logo MSD Human Health Holding BV

MSD Human Health Holding BV

Pharmaceuticals: MajorHealth Technology

Part of Merck & Co., Inc., MSD Human Health Holding BV discovers, develops and markets human and animal health products. The company is based in Oss, Netherlands.

Pharmaceuticals: Major
Merck Sharp & Dohme LLC
Logo Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC

Pharmaceuticals: MajorHealth Technology

Part of Merck & Co., Inc., Merck Sharp & Dohme LLC is a pharmaceutical company. The company is based in Kenilworth, NJ.

Pharmaceuticals: Major
Merck Sharp & Dohme Corp.
Logo Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp.

Pharmaceuticals: MajorHealth Technology

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Pharmaceuticals: Major
Essex Chemie AG
Merck Sharp & Dohme BV
Logo Merck Sharp & Dohme BV

Merck Sharp & Dohme BV

Pharmaceuticals: MajorHealth Technology

Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The company is based in Haarlem, the Netherlands.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.55% 79TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.45% 63TCr
ABBVIE INC. Stock AbbVie Inc.
+9.09% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.32% 25TCr
ROCHE HOLDING AG Stock Roche Holding AG
+0.41% 22TCr
NOVARTIS AG Stock Novartis AG
+10.22% 22TCr
AMGEN INC. Stock Amgen Inc.
+4.55% 16TCr
PFIZER, INC. Stock Pfizer, Inc.
-5.78% 16TCr
SANOFI Stock Sanofi
-2.33% 12TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. 0QAH Stock
  5. Company Merck & Co., Inc.